Hikma Pharmaceuticals (LON:HIK) Stock Price Up 7.6% – Here’s What Happened

Hikma Pharmaceuticals PLC (LON:HIK) shares were up 7.6% during mid-day trading on Tuesday . The company traded as high as GBX 1,670 and last traded at GBX 1,661. 1,945,266 shares traded hands during trading, a decline of 67% from the average daily volume of 5,900,212 shares. The stock had previously closed at GBX 1,544.

Analysts Set New Price Targets

A number of analysts have weighed in on HIK shares. Berenberg Bank reissued a “buy” rating and set a GBX 1,800 target price on shares of Hikma Pharmaceuticals in a research report on Tuesday, April 28th. Jefferies Financial Group upped their price target on shares of Hikma Pharmaceuticals from GBX 1,850 to GBX 1,870 and gave the company a “buy” rating in a research report on Tuesday, May 5th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 195 price target on shares of Hikma Pharmaceuticals in a report on Monday, June 22nd. Five investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of GBX 1,687.

Hikma Pharmaceuticals Trading Up 7.6%

The firm’s 50 day simple moving average is GBX 1,462.26 and its two-hundred day simple moving average is GBX 1,445.59. The stock has a market capitalization of £3.53 billion, a P/E ratio of 9.18, a P/E/G ratio of 2.38 and a beta of 0.65. The company has a quick ratio of 1.27, a current ratio of 1.82 and a debt-to-equity ratio of 61.84.

Hikma Pharmaceuticals Company Profile

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 820+ (as of Feb 2026) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.